Thursday April 25, 2024 | Last Update: April 25, 2024 EDT
Shire Plc, a company that develops and delivers innovative medicines for patients with rare disease, is preparing to make a new takeover offer to Baxalta, Inc., a source with direct knowledge of the matter told Reuters. The acquisition, if successful, will create one of the world’s leading specialists in rare disease.
Read more >>
Shire Plc has announced that they have made a proposal to Baxalta, Inc. on July 10, 2015 for a possible merger in an “all-stock transaction,” according to the press release issued by Shire.
Just In
Most Read
1
2
3
4
5
